Boeing's growth is underpinned by operating leverage, excess production capacity, and a robust backlog, as regulatory ...

Vor Biopharma pivots to telitacicept for autoimmune diseases, backed by $491M cash to 2029. Click here to read an analysis of ...

This British comedy on Hulu centers on two 50-something best friends who turn on each other after he gets involved with her ...

Experts broadly welcomed the recommendations of the review, but some warned that alignment between regulators and firms was ...

Small cap funds saw significant inflows in May 2026 after a poor 2025. Despite market volatility, advisors suggest staggered ...

Former DAA boss will help spearhead US expansion for start-up that has pulled the plug on Irish deliveries over planning ...